| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |